Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. (ALNY) — Form 10-Q: Quarterly report

10-QALNYFiled Jul 30, 2026, 4:11 AM ET· Period Jun 30, 2026

About this filing

Alnylam Pharmaceuticals, Inc. (ALNY) filed Form 10-Q (quarterly report) with the SEC on Jul 30, 2026. A 10-Q is the company’s quarterly financial report.

View original filing on SEC.gov

Key facts

Document: 10-Q

More ALNY filings

SC 13G
Ownership over 5% (passive)
Filed Oct 30, 2026
10-Q
Quarterly report
Filed Oct 29, 2026
8-K
Current report
Filed Oct 29, 2026
4
Insider transaction
Filed Oct 6, 2026
144
Proposed sale of shares
Filed Oct 2, 2026
4
Insider transaction
Filed Sep 22, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.